liveBook · Manning

Molecular property prediction

As explained in Build AI Drug Discovery Pipelines

Molecular property prediction is the computational prediction of chemical or biological properties from molecular representations.

Molecular property prediction uses computational models to estimate chemical or biological properties from molecular structure. In drug discovery, it helps identify promising compounds before committing to expensive experiments. section 1.0 section 1.3.1

A machine-learning property-prediction workflow can:

  • Take a compound and its structure as input, then predict whether it meets desired criteria such as low toxicity or high binding affinity. section 1.3.1
  • Estimate properties such as solubility and toxicity when sufficient, high-quality experimental data is available for training. section 1.3.1
  • Screen large compound libraries computationally, reducing the number of molecules requiring experimental testing. section 1.3.1
  • Replace some expensive docking calculations with direct binding-affinity prediction for targets represented in the training data. section 1.3.1
Figure 1.8 Using AI to guide early prediction and optimization of drug-like molecules, we can broaden the number of considered candidate molecules, identify failures earlier when they are relatively inexpensive, and accelerate delivery of novel therapeutics to the clinic for patient benefit.

AI-guided early prediction and optimization can broaden the candidate set, expose failures sooner, and support faster therapeutic development. section 1.3.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Defines direct property prediction and contrasts it with docking, but defers detailed model construction and evaluation.
Examples
Uses solubility, toxicity, and target binding affinity as predicted properties, contrasting predictions with docking and molecular-dynamics simulations.
What it assumes
Builds on computational molecular representations and basic machine-learning concepts established before application examples.
What you can do after
Apply machine-learning models to prioritize drug candidates by predicted properties and reduce unnecessary experimental screening.
How it connects
Connects virtual screening with molecular docking, molecular dynamics, binding affinity, solubility, toxicity, and deep learning.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.